Trial Outcomes & Findings for Cadence and Intensity in Children and Adolescents (CADENCE-KIDS) (NCT NCT01989104)

NCT ID: NCT01989104

Last Updated: 2022-12-01

Results Overview

Cadence steps per minute represents an overlooked opportunity to describe the intensity of ambulatory activity.

Recruitment status

COMPLETED

Target enrollment

123 participants

Primary outcome timeframe

1 day

Results posted on

2022-12-01

Participant Flow

Participant milestones

Participant milestones
Measure
Children Group 1
6-8 years of age
Children Group 2
9-11 years of age
Adolescents Group 1
12-14 years of age
Adolescents Group 2
15-17 years of age
Young Adults
18-20 years of age
Overall Study
STARTED
25
25
25
24
24
Overall Study
COMPLETED
22
25
25
24
24
Overall Study
NOT COMPLETED
3
0
0
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Children Group 1
6-8 years of age
Children Group 2
9-11 years of age
Adolescents Group 1
12-14 years of age
Adolescents Group 2
15-17 years of age
Young Adults
18-20 years of age
Overall Study
Withdrawal by Subject
3
0
0
0
0

Baseline Characteristics

Cadence and Intensity in Children and Adolescents (CADENCE-KIDS)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Children Group 1
n=22 Participants
6-8 years of age
Children Group 2
n=25 Participants
9-11 years of age
Adolescents Group 1
n=25 Participants
12-14 years of age
Adolescents Group 2
n=24 Participants
15-17 years of age
Young Adults
n=24 Participants
18-20 years of age
Total
n=120 Participants
Total of all reporting groups
Age, Categorical
<=18 years
22 Participants
n=5 Participants
25 Participants
n=7 Participants
25 Participants
n=5 Participants
24 Participants
n=4 Participants
0 Participants
n=21 Participants
96 Participants
n=8 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
24 Participants
n=21 Participants
24 Participants
n=8 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
Sex: Female, Male
Female
10 Participants
n=5 Participants
13 Participants
n=7 Participants
13 Participants
n=5 Participants
12 Participants
n=4 Participants
12 Participants
n=21 Participants
60 Participants
n=8 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
12 Participants
n=7 Participants
12 Participants
n=5 Participants
12 Participants
n=4 Participants
12 Participants
n=21 Participants
60 Participants
n=8 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
3 Participants
n=8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
Race (NIH/OMB)
Black or African American
9 Participants
n=5 Participants
5 Participants
n=7 Participants
10 Participants
n=5 Participants
11 Participants
n=4 Participants
7 Participants
n=21 Participants
42 Participants
n=8 Participants
Race (NIH/OMB)
White
11 Participants
n=5 Participants
19 Participants
n=7 Participants
15 Participants
n=5 Participants
13 Participants
n=4 Participants
17 Participants
n=21 Participants
75 Participants
n=8 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
Region of Enrollment
United States
22 Participants
n=5 Participants
25 Participants
n=7 Participants
25 Participants
n=5 Participants
24 Participants
n=4 Participants
24 Participants
n=21 Participants
120 Participants
n=8 Participants

PRIMARY outcome

Timeframe: 1 day

Cadence steps per minute represents an overlooked opportunity to describe the intensity of ambulatory activity.

Outcome measures

Outcome measures
Measure
Children Group 1
n=22 Participants
6-8 years of age
Children Group 2
n=25 Participants
9-11 years of age
Adolescents Group 1
n=25 Participants
12-14 years of age
Adolescents Group 2
n=24 Participants
15-17 years of age
Young Adults
n=24 Participants
18-20 years of age
Cadence - Steps Per Minute
Moderate Intensity
128.4 Cadence - Steps per Minute
Interval 121.7 to 134.5
116.5 Cadence - Steps per Minute
Interval 109.3 to 123.9
106.6 Cadence - Steps per Minute
Interval 102.5 to 111.0
101.3 Cadence - Steps per Minute
Interval 97.5 to 104.8
87.3 Cadence - Steps per Minute
Interval 79.4 to 95.7
Cadence - Steps Per Minute
Vigorous Intensity
157.7 Cadence - Steps per Minute
Interval 151.8 to 164.0
142.7 Cadence - Steps per Minute
Interval 134.6 to 152.8
129.3 Cadence - Steps per Minute
Interval 124.1 to 135.6
126.3 Cadence - Steps per Minute
Interval 122.9 to 129.8
129.9 Cadence - Steps per Minute
Interval 126.3 to 133.6

Adverse Events

Children Group 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Children Group 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Adolescents Group 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Adolescents Group 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Young Adults

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. William Johnson

Pennington Biomedical Research Center

Phone: 225-763-2932

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place